Who we helpSadly, Breast Cancer claims the lives of around 12,000 women each year.
The number of women being diagnosed is rising, but the good news is that with your help, more women are surviving the disease than ever before. Learn More
A clinical trial has found that precision medicine – or tailoring treatment for individual patients – can delay the time it takes for a tumour to grow back in some types of advanced cancer. This trial took place at Gustave Roussy Cancer Campus in Paris and was presented at the Molecular Analysis for Personalised Therapy ...more
16 – 18 September 2016 We had such a great time at Kirsty Allsopp’s The Handmade Fair last weekend with our partners DMC Creative World Ltd The setting was The Green at Hampton Court Palace and although the weather was pretty miserable at times, we met some fantastic people and got to know the team behind our ...more
STAND UP TO CANCER and Channel 4 are looking for a single lady who has beaten and survived cancer to take part in a live night of fundraising on Friday 21st October, hosted by Davina McCall, Alan Carr and Adam Hills. Are you aged 18-30 and looking for love or dating? If so, we want to ...more
“Women who take a common form of HRT are nearly three times as likely to get breast cancer, a major study has found,” the Daily Mail reports. Hormone replacement therapy (HRT) is a treatment used to relieve symptoms of the menopause, such as hot flushes. It replaces hormones that typically drop to a lower level during the ...more
Scientists have raised the possibility of using statins, cholesterol reducing drugs, to stop some breast cancers returning. The most common form of breast cancer in the UK is oestrogen receptor (ER) positive which uses oestrogen to grow. Hormone therapy drugs such as ‘tamoxifen’ and aromatase inhibitors cut off the supply of oestrogen, reducing the chances the ...more
Earlier this week saw an agreement signed between UK cancer clinical trial centers making new clinical trials easier and more efficient to set up. The Experimental Cancer Medical Centre (ECMC) collaboration agreement will improve the UK’s ability to carry out early phase trials, boosting research to bring new treatments to patients sooner. The UK currently faces ...more
According to research published in the journal Oncogene earlier this week, researchers from Nottingham and Oxford Universities have found a new technique to slow the growth of one of the most aggressive forms of breast cancer. The drug, called JQ1, has shown promising results both in vitro and on human cancer cells in mice, and ...more
Dr Niamh Buckley and her team at Queen’s University Belfast, have discovered a way to predict the likelihood that women who are diagnosed with non-invasive breast cancer will go on to develop an invasive form of the disease. This information could enable doctors to tailor the patient’s treatment to their specific needs. In the UK there ...more
Personalised treatment for breast cancer could become commonplace as scientists reveal they have compiled the most detailed picture of which genetic mutations are involved in the disease. The findings were published in the journals ‘Nature’ and ‘Nature Communications’ and explain which genes cause healthy breast tissue to turn cancerous. Researchers from the Sanger Institute in Cambridge ...more
Following on from last week’s article Scientists hail ‘Milestone’ genetic find for breast cancer which looked at which mutated genes are more likely to cause cancer, scientists have been able to use this data to analyse that breast cancer can be classified into 10 different diseases. By researching these 10 subtypes of breast cancer scientists at ...more
Jonathan Prince, Trustee. The Pink Ribbon Foundation.
Crofton House, 5 Morley Close, Orpington, Kent BR6 8JR
(t) 01689 858877 (e) firstname.lastname@example.org.
Charity Number 1080839